ロード中...
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Chimeric antigen receptor (CAR) T cells are a novel class of anti-cancer therapy in which autologous or allogeneic T cells are engineered to express a CAR targeting a membrane antigen. In Europe, tisagenlecleucel (Kymriah™) is approved for the treatment of refractory/relapsed acute lymphoblastic leu...
保存先:
| 出版年: | Haematologica |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ferrata Storti Foundation
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7012497/ https://ncbi.nlm.nih.gov/pubmed/31753925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.229781 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|